Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Detection of immunoglobulin light chain restrication by rna in situ hybridization

A technique of immunoglobulin and in situ hybridization, applied in the filed U.S. Provisional Application Serial No. 61

Inactive Publication Date: 2015-05-13
ADVANCED CELL DIAGNOSTICS INC +1
View PDF21 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, autoradiographic signals take two weeks or more to develop (Segal et al., supra, 1994), and this delay is unacceptable for clinical control

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Detection of immunoglobulin light chain restrication by rna in situ hybridization
  • Detection of immunoglobulin light chain restrication by rna in situ hybridization
  • Detection of immunoglobulin light chain restrication by rna in situ hybridization

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0120] Detection of Immunoglobulin Light Chain Restriction in B Cells Using In Situ Hybridization

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a method for detecting immunoglobulin light chain restriction and clonality in B cells by obtaining a sample of B cells from a subject; conducting a duplex in situ hybridization assay on the sample using (i) at least one probe set which is designed to specifically hybridize to immunoglobulin kappa chain constant region (IGKCR) RNA; and (ii) at least one probe set which is designed to specifically hybridize to immunoglobulin lambda chain constant region (IGLCR) RNA; detecting signal associated with hybridized IGKCR probe and signal associated with hybridized IGLCR probe in a population of B cells in the sample; and determining a pattern of signal associated with hybridized IGKCR probe and hybridized IGLCR probe within individual cells in the B cell population, wherein the pattern of signal within individual cells indicates the presence or absence of light chain restriction and clonality of the B cells.

Description

[0001] This application claims priority to U.S. Application Serial No. 13 / 843408, filed March 15, 2013, and U.S. Provisional Application Serial No. 61 / 620634, filed April 5, 2012, and 2012 Priority to U.S. Provisional Application Serial No. 61 / 717064, filed October 22, each of which is hereby incorporated by reference in its entirety. [0002] This invention was made with government support under Grant No. R43CA168019 awarded by the National Cancer Institute. The government has certain rights in this invention. Background technique [0003] The present invention relates generally to in situ hybridization assays, and more particularly to assays for diagnosing B cell neoplasms. [0004] Immunoglobulins are composed of two heavy chains and two light chains. During B-cell differentiation, DNA encoding immunoglobulin genes undergoes rearrangements to produce a unique combination of immunoglobulin domains with a greater diversity of possible immunoglobulins available to an individ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/68
CPCC07K16/00C12Q1/6881C12Q1/6886C12Q2600/158C07K2317/515C12Q2600/112
Inventor 马小骏罗宇龄雷蒙德·塔布斯
Owner ADVANCED CELL DIAGNOSTICS INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products